RTI Surgical Inc (NASDAQ:RTIX)

5.12
Data as of Sep 19
 -0.01 / -0.19%
Today’s Change
2.77
Today|||52-Week Range
5.58
+44.63%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$290.9M

Company Description

RTI Surgical, Inc. provides sterile biological implants for surgeries around the world. The company recovers and processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine animal tissue in producing allograft and xenograft implants utilizing proprietary BIOCLEANSE and TUTOPLAST sterilization processes, for distribution to hospitals and surgeons. It produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues, and improve surgical outcomes. The company's business lines are comprised of five categories: Sports Medicine, Spine, Surgical Specialties, Bone Graft Substitutes & General Orthopedic, and Dental. The Sports Medicine business category's implants and products include BioCleanse Meniscus, Bone-Tendon-Bone Select, BioCleanse Peroneus Longus, Sterling Xenograft Wedge, osteochondral and Matrix HD. Its allografts are tendons for ligament reconstruction and meniscal allografts are for transplantation. The Spine business includes precision machined implants and bone paste utilized in spinal procedures. The Surgical Specialties business distributes implants for hernia, breast reconstruction, urology, ophthalmology, and ENT. The orthopedic business includes General Orthopedic and Trauma Allografts and Bone Graft Substitutes. The Dental business provides various implants including cancellous and cortical bone and human and bovine membranes primarily for dental procedures related to augmenting ridge restoration. The company was founded on February 27, 2008 and is headquartered in Alachua, FL.

Contact Information

RTI Surgical, Inc.
11621 Research Circle
Alachua Florida 32615
P:(386) 418-8888
Investor Relations:

Employees

Shareholders

Other institutional46.67%
Mutual fund holders21.67%
Individual stakeholders11.63%

Top Executives

Brian K. HutchisonPresident, Chief Executive Officer & Director
Robert P. JordheimCFO, Executive VP & Head-Investor Relations
Caroline A. HartillChief Scientific Officer & Executive VP
Lennox K. ArchibaldMedical Director
Thomas F. RoseSecretary & Executive VP-Administration

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.